Allergan has entered into a licensing agreement with Mimetogen Pharmaceuticals to develop and commercialize tavilermide, a topical formulation of a novel small molecule TrkA agonist for the treatment of dry eye disease, according to an Allergan press r…
SEATTLE–(BUSINESS WIRE)–Acucela Inc. (TOKYO:4589), a clinical-stage biotechnology company that specializes in discovering and developing novel drug candidates to potentially treat and slow the progression of sight-threatening ophthalmic diseases, has validated an analytical method that could lead to significant cost savings in the collection of blood samples as part of the company’s clinical trials of emixustat hydrochloride (emixustat), the company announced today. Emixustat, the first inter
An 80-year-old woman presents for a routine eye exam 2 years after undergoing cataract extraction and intraocular lens implantation. What is the cause of her decreased vision? Medscape Optometry
RAMSEY, Minn.–(BUSINESS WIRE)–Ophthalmic lens manufacturer VISION EASE immediately expands its product portfolio and distribution capabilities with the acquisition of Daemyung Optical Co. Ltd. (DMO).
SAN DIEGO–(BUSINESS WIRE)–ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system disorders, today announced that it will present at the 24th Annual Credit Suisse Healthcare Conference on Tuesday, November 10, 2015, at 11:30 a.m. Mountain Standard Time in Scottsdale, Arizona. A live webcast of ACADIA’s presentation will be accessible on the company’
NEW YORK — At OSN New York 2015, Nicole R. Fram, MD, gives pearls on using the Hoffman pocket technique.